Ocular ischemic syndrome – case report and literature analysis

[1] Terelak-Borys B, Skonieczna K, Grabska-Liberek I. Ocular ischemic syndrome - a systematic review. Med Sci Monit. Aug 2012;18(8):RA138–144. Terelak-BorysB SkoniecznaK Grabska-LiberekI Ocular ischemic syndrome - a systematic review Med Sci Monit. Aug 2012 18 8 RA138 144 Search in Google Scholar

[2] Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome. Surv Ophthalmol. Jan–Feb 2010;55(1):2–34. MendrinosE MachinisTG PournarasCJ Ocular ischemic syndrome Surv Ophthalmol. Jan–Feb 2010 55 1 2 34 Search in Google Scholar

[3] Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Mizota A, Tormene AP; International Society for Clinical Electrophysiology of Vision. ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol. 2016;133:1–9.. OdomJV BachM BrigellM HolderGE McCullochDL MizotaA TormeneAP International Society for Clinical Electrophysiology of Vision ISCEV standard for clinical visual evoked potentials: (2016 update) Doc Ophthalmol. 2016 133 1 9 Search in Google Scholar

[4] Kearns TP, Hollenhorst RW. Venous stasis retinopathy of occlusive disease of the carotid artery. Mayo Clin Proc. 1963;38:304–12. KearnsTP HollenhorstRW Venous stasis retinopathy of occlusive disease of the carotid artery Mayo Clin Proc. 1963 38 304 12 Search in Google Scholar

[5] Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome. Surv Ophthalmol 2010;55:2–34. MendrinosE MachinisTG PournarasCJ Ocular ischemic syndrome Surv Ophthalmol 2010 55 2 34 Search in Google Scholar

[6] Hung JH, Chang YS. Ocular ischemic syndrome. CMAJ. 12 June 2017;189(23):E804. HungJH ChangYS Ocular ischemic syndrome CMAJ. 12 June 2017 189 23 E804 Search in Google Scholar

[7] Mizener JB, Podhajsky P, Hayreh SS. Ocular ischemic syndrome. Ophthalmology. 1997;104:859–64. MizenerJB PodhajskyP HayrehSS Ocular ischemic syndrome Ophthalmology. 1997 104 859 64 Search in Google Scholar

[8] Sharma S, Brown GC. In: Ocular Ischemic Syndrome. Ryan SJ, Hinton DR, Schachat AP, et al., editors. Elsevier; 2006. SharmaS BrownGC In: Ocular Ischemic Syndrome RyanSJ HintonDR SchachatAP editors. Elsevier 2006 Search in Google Scholar

[9] Sivalingam A, Brown GC, Magargal LE. The ocular ischemic syndrome. III. Visual prognosis and the effect of treatment. Int Ophthalmol. 1991;15(1):15–20. SivalingamA BrownGC MagargalLE The ocular ischemic syndrome. III. Visual prognosis and the effect of treatment Int Ophthalmol. 1991 15 1 15 20 Search in Google Scholar

[10] Brown GC, Magargal LE. The ocular ischemic syndrome. Clinical, fluorescein angiographic and carotid angiographic features. Int Ophthalmol. 1988;11(4):239–51. BrownGC MagargalLE The ocular ischemic syndrome. Clinical, fluorescein angiographic and carotid angiographic features Int Ophthalmol. 1988 11 4 239 51 Search in Google Scholar

[11] Kerty E, Eide N. Chronic ocular ischaemia. Acta Ophthalmol. 1989;67(4):386–92. KertyE EideN Chronic ocular ischaemia Acta Ophthalmol. 1989 67 4 386 92 Search in Google Scholar

[12] Brown GC. Macular edema in association with severe carotid artery obstruction. Am J Ophthalmol. 1986;102(4):442–48. BrownGC Macular edema in association with severe carotid artery obstruction Am J Ophthalmol. 1986 102 4 442 48 Search in Google Scholar

[13] Berkow JW, Flower RW, Orth DH, Kelley JS. Angiografia fluoresceinowa i indocyjaninowa. Wrocław: Górnicki Wydawnictwo Medyczne; 2004. BerkowJW FlowerRW OrthDH KelleyJS Angiografia fluoresceinowa i indocyjaninowa Wrocław Górnicki Wydawnictwo Medyczne 2004 Search in Google Scholar

[14] Chen CS, Miller NR. Ocular ischemic syndrome: review of clinical presentations, etiology, investigation, and management. Compr Ophthalmol Update. 2007;8(1):17–28. ChenCS MillerNR Ocular ischemic syndrome: review of clinical presentations, etiology, investigation, and management Compr Ophthalmol Update. 2007 8 1 17 28 Search in Google Scholar

[15] Hashimoto M, Ohtsuka K, Ohtsuka H, Nakagawa T. Normal-tension glaucoma with reversed ophthalmic artery flow. Am J Ophthalmol. 2000;130(5):670–72. HashimotoM OhtsukaK OhtsukaH NakagawaT Normal-tension glaucoma with reversed ophthalmic artery flow Am J Ophthalmol. 2000 130 5 670 72 Search in Google Scholar

[16] Kofoed PK, Munch IC, Sander B, Holfort SK, Sillesen H, Jensen LP, Larsen M. Prolonged multifocal electroretinographic implicit times in the ocular ischemic syndrome. Invest Ophthalmol Vis Sci. 2010;51:1806–10. KofoedPK MunchIC SanderB HolfortSK SillesenH JensenLP LarsenM Prolonged multifocal electroretinographic implicit times in the ocular ischemic syndrome Invest Ophthalmol Vis Sci. 2010 51 1806 10 Search in Google Scholar

[17] Duker, J. S., Brown, G. C., Bosley, T. M., Colt, C. A., & Reber, R. Asymmetric proliferative diabetic retinopathy and carotid artery disease. Ophthalmology. 1990;97(7):869–874. DukerJ. S. BrownG. C. BosleyT. M. ColtC. A. ReberR. Asymmetric proliferative diabetic retinopathy and carotid artery disease Ophthalmology 1990 97 7 869 874 Search in Google Scholar

[18] Jingyi L, Zhichao Y, Yu J, Rongjiang L. Clinical analysis of 42 cases of ocular ischemic syndrome. Journal of Ophthalmology. 2018. JingyiL ZhichaoY YuJ RongjiangL Clinical analysis of 42 cases of ocular ischemic syndrome Journal of Ophthalmology 2018 Search in Google Scholar

[19] Wierzbowska J, Robaszkiewicz J, Figurska M, Stankiewicz A. Future possibilities in glaucoma therapy. Med Sci Monit. 2010;16:RA252–9. WierzbowskaJ RobaszkiewiczJ FigurskaM StankiewiczA Future possibilities in glaucoma therapy Med Sci Monit. 2010 16 RA252 9 Search in Google Scholar

[20] Dzierwa K, Pieniazek P, Musialek P, Piatek J, Tekieli L, Podolec P, Drwiła R, Hlawaty M, Trystuła M, Motyl R, et al. Treatment strategies in severe symptomatic carotid and coronary artery disease. Med Sci Monit. 2011;17:RA191–197. DzierwaK PieniazekP MusialekP PiatekJ TekieliL PodolecP DrwiłaR HlawatyM TrystułaM MotylR Treatment strategies in severe symptomatic carotid and coronary artery disease Med Sci Monit. 2011 17 RA191 197 Search in Google Scholar